Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 27

1.
2.

Reply to: Point-of-care ultrasound during advanced cardiopulmonary resuscitation: Rule of art have to be respected!

Allison M, Winters ME, Huis In 't Veld OBOMA, Bostick DS, Witting M, Fisher KR, Goloubeva OG.

Resuscitation. 2018 Jan;122:e3. doi: 10.1016/j.resuscitation.2017.11.051. No abstract available.

PMID:
29254581
3.

Ultrasound use during cardiopulmonary resuscitation is associated with delays in chest compressions.

Huis In 't Veld MA, Allison MG, Bostick DS, Fisher KR, Goloubeva OG, Witting MD, Winters ME.

Resuscitation. 2017 Oct;119:95-98. doi: 10.1016/j.resuscitation.2017.07.021. Epub 2017 Jul 25.

PMID:
28754527
4.

Non-specific binding and steric hindrance thresholds for penetration of particulate drug carriers within tumor tissue.

Dancy JG, Wadajkar AS, Schneider CS, Mauban JRH, Goloubeva OG, Woodworth GF, Winkles JA, Kim AJ.

J Control Release. 2016 Sep 28;238:139-148. doi: 10.1016/j.jconrel.2016.07.034. Epub 2016 Jul 25.

5.

Patient-reported Adherence to Adjuvant Aromatase Inhibitor Therapy Using the Morisky Medication Adherence Scale: An Evaluation of Predictors.

Kesmodel SB, Goloubeva OG, Rosenblatt PY, Heiss B, Bellavance EC, Chumsri S, Bao T, Thompson J, Nightingale G, Tait NS, Nichols EM, Feigenberg SJ, Tkaczuk KH.

Am J Clin Oncol. 2018 May;41(5):508-512. doi: 10.1097/COC.0000000000000314.

PMID:
27322700
7.

The RUNX2 Transcription Factor Negatively Regulates SIRT6 Expression to Alter Glucose Metabolism in Breast Cancer Cells.

Choe M, Brusgard JL, Chumsri S, Bhandary L, Zhao XF, Lu S, Goloubeva OG, Polster BM, Fiskum GM, Girnun GD, Kim MS, Passaniti A.

J Cell Biochem. 2015 Oct;116(10):2210-26. doi: 10.1002/jcb.25171.

8.

α-Tubulin acetylation elevated in metastatic and basal-like breast cancer cells promotes microtentacle formation, adhesion, and invasive migration.

Boggs AE, Vitolo MI, Whipple RA, Charpentier MS, Goloubeva OG, Ioffe OB, Tuttle KC, Slovic J, Lu Y, Mills GB, Martin SS.

Cancer Res. 2015 Jan 1;75(1):203-15. doi: 10.1158/0008-5472.CAN-13-3563. Epub 2014 Dec 12.

9.

Disparities in black and white patients with multiple myeloma referred for autologous hematopoietic transplantation: a single center study.

Bhatnagar V, Wu Y, Goloubeva OG, Ruehle KT, Milliron TE, Harris CG, Rapoport AP, Yanovich S, Sausville EA, Baer MR, Badros AZ.

Cancer. 2015 Apr 1;121(7):1064-70. doi: 10.1002/cncr.29160. Epub 2014 Dec 2.

10.

Emergence of HPV16-positive oropharyngeal cancer in Black patients over time: University of Maryland 1992-2007.

Zandberg DP, Liu S, Goloubeva OG, Schumaker LM, Cullen KJ.

Cancer Prev Res (Phila). 2015 Jan;8(1):12-9. doi: 10.1158/1940-6207.CAPR-14-0089-T. Epub 2014 Jun 10.

11.

HDAC inhibitor entinostat restores responsiveness of letrozole-resistant MCF-7Ca xenografts to aromatase inhibitors through modulation of Her-2.

Sabnis GJ, Goloubeva OG, Kazi AA, Shah P, Brodie AH.

Mol Cancer Ther. 2013 Dec;12(12):2804-16. doi: 10.1158/1535-7163.MCT-13-0345. Epub 2013 Oct 3.

12.

Metformin prevents liver tumorigenesis by inhibiting pathways driving hepatic lipogenesis.

Bhalla K, Hwang BJ, Dewi RE, Twaddel W, Goloubeva OG, Wong KK, Saxena NK, Biswal S, Girnun GD.

Cancer Prev Res (Phila). 2012 Apr;5(4):544-52. doi: 10.1158/1940-6207.CAPR-11-0228. Epub 2012 Mar 31.

13.

Computer assisted quantitative immunofluorescence of tumor tissue marker expression and clinical outcome to chemotherapy in advanced breast cancer patients.

Tkaczuk KH, Tait NS, Ioffe O, Tan M, Goloubeva OG, Lesko SA, Deamond SF, Zhou D, Lum ZP, Sutula MJ, Van Echo D, Ts'o PO.

Discov Med. 2011 Jul;12(62):33-40.

14.

Combination of anastrozole with fulvestrant in the intratumoral aromatase xenograft model.

Macedo LF, Sabnis GJ, Goloubeva OG, Brodie A.

Cancer Res. 2008 May 1;68(9):3516-22. doi: 10.1158/0008-5472.CAN-07-6807.

15.

Germinal center function in the spleen during simian HIV infection in rhesus monkeys.

Margolin DH, Saunders EH, Bronfin B, de Rosa N, Axthelm MK, Goloubeva OG, Eapen S, Gelman RS, Letvin NL.

J Immunol. 2006 Jul 15;177(2):1108-19.

16.

Stage-associated overexpression of the ubiquitin-like protein, ISG15, in bladder cancer.

Andersen JB, Aaboe M, Borden EC, Goloubeva OG, Hassel BA, Orntoft TF.

Br J Cancer. 2006 May 22;94(10):1465-71.

17.

Mitochondrial DNA content increase in response to cigarette smoking.

Masayesva BG, Mambo E, Taylor RJ, Goloubeva OG, Zhou S, Cohen Y, Minhas K, Koch W, Sciubba J, Alberg AJ, Sidransky D, Califano J.

Cancer Epidemiol Biomarkers Prev. 2006 Jan;15(1):19-24.

18.

Additive antitumor effect of aromatase inhibitor letrozole and antiestrogen fulvestrant in a postmenopausal breast cancer model.

Jelovac D, Macedo L, Goloubeva OG, Handratta V, Brodie AM.

Cancer Res. 2005 Jun 15;65(12):5439-44.

19.

Activation of mitogen-activated protein kinase in xenografts and cells during prolonged treatment with aromatase inhibitor letrozole.

Jelovac D, Sabnis G, Long BJ, Macedo L, Goloubeva OG, Brodie AM.

Cancer Res. 2005 Jun 15;65(12):5380-9.

20.

Phase I clinical trial of the inosine monophosphate dehydrogenase inhibitor mycophenolate mofetil (cellcept) in advanced multiple myeloma patients.

Takebe N, Cheng X, Wu S, Bauer K, Goloubeva OG, Fenton RG, Heyman M, Rapoport AP, Badros A, Shaughnessy J, Ross D, Meisenberg B, Tricot G.

Clin Cancer Res. 2004 Dec 15;10(24):8301-8.

21.

Novel retinoic acid metabolism blocking agents endowed with multiple biological activities are efficient growth inhibitors of human breast and prostate cancer cells in vitro and a human breast tumor xenograft in nude mice.

Patel JB, Huynh CK, Handratta VD, Gediya LK, Brodie AM, Goloubeva OG, Clement OO, Nanne IP, Soprano DR, Njar VC.

J Med Chem. 2004 Dec 30;47(27):6716-29.

PMID:
15615521
22.

Effects of exemestane and tamoxifen in a postmenopausal breast cancer model.

Jelovac D, Macedo L, Handratta V, Long BJ, Goloubeva OG, Ingle JN, Brodie AM.

Clin Cancer Res. 2004 Nov 1;10(21):7375-81.

23.

Ionizing radiation induces delayed hyperrecombination in Mammalian cells.

Huang L, Grim S, Smith LE, Kim PM, Nickoloff JA, Goloubeva OG, Morgan WF.

Mol Cell Biol. 2004 Jun;24(11):5060-8.

24.

Therapeutic strategies using the aromatase inhibitor letrozole and tamoxifen in a breast cancer model.

Long BJ, Jelovac D, Handratta V, Thiantanawat A, MacPherson N, Ragaz J, Goloubeva OG, Brodie AM.

J Natl Cancer Inst. 2004 Mar 17;96(6):456-65.

PMID:
15026471
25.

Nephrotoxicity of iopamidol in pediatric, adolescent, and young adult patients who have undergone allogeneic bone marrow transplantation.

Haight AE, Kaste SC, Goloubeva OG, Xiong XP, Bowman LC.

Radiology. 2003 Feb;226(2):399-404.

PMID:
12563132
26.

Comparison of efficacies of RWJ-270201, zanamivir, and oseltamivir against H5N1, H9N2, and other avian influenza viruses.

Govorkova EA, Leneva IA, Goloubeva OG, Bush K, Webster RG.

Antimicrob Agents Chemother. 2001 Oct;45(10):2723-32.

27.

Supplemental Content

Loading ...
Support Center